Literature DB >> 17078005

Susceptibility-guided vs. empiric retreatment of Helicobacter pylori infection after treatment failure.

Jacob Yahav1, Zmira Samra, Yaron Niv, Charlesnika T Evans, Douglas J Passaro, Gabriel Dinari, Haim Shmuely.   

Abstract

Successful eradication of Helicobacter pylori after failure of standard triple therapy is difficult because of the higher resistance to metronidazole and clarithromycin. We evaluated the efficacy of susceptibility-guided vs. empiric retreatment for H. pylori after at least one treatment failure and determined the prevalence of posttreatment antibiotic resistance. Forty-nine patients in whom at least one treatment regimen for H. pylori eradication had failed underwent gastric biopsy and culture and were retreated according to the in vitro susceptibility results. Findings were compared with those for 49 control patients referred to our center for a (13)C-urea breath test. H. pylori eradication was assessed by urea breath test at least 6 weeks after retreatment in both groups. Susceptibility-guided retreatment was associated with better eradication rates than empiric treatment. The difference remained significant in stratified and multivariate analysis. Susceptibility-guided retreatment appears to be significantly more effective than empiric retreatment in eradicating H. pylori after at least one previous treatment failure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17078005     DOI: 10.1007/s10620-006-9302-2

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  25 in total

1.  Triple therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer disease: results of a multicentre study in South-East Asia. South-East Asia Multicenter Study Group.

Authors:  K M Fock; P Chelvam; S G Lim
Journal:  Aliment Pharmacol Ther       Date:  2000-02       Impact factor: 8.171

2.  One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group.

Authors:  J J Misiewicz; A W Harris; K D Bardhan; S Levi; C O'Morain; B T Cooper; G D Kerr; M F Dixon; H Langworthy; D Piper
Journal:  Gut       Date:  1997-12       Impact factor: 23.059

3.  Resistance of Helicobacter pylori isolated in Israel to metronidazole, clarithromycin, tetracycline, amoxicillin and cefixime.

Authors:  Zmira Samra; Haim Shmuely; Yaron Niv; Gabriel Dinari; Douglas J Passaro; Alex Geler; Eyal Gal; Michal Fishman; Jacklin Bachor; Jacob Yahav
Journal:  J Antimicrob Chemother       Date:  2002-06       Impact factor: 5.790

Review 4.  Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report.

Authors:  P Malfertheiner; F Mégraud; C O'Morain; A P S Hungin; R Jones; A Axon; D Y Graham; G Tytgat
Journal:  Aliment Pharmacol Ther       Date:  2002-02       Impact factor: 8.171

5.  Helicobacter pylori primary resistance to metronidazole and clarithromycin in Brazil.

Authors:  Paula Prazeres Magalhães; Dulciene Maria De Magalhães Queiroz; Daniela Vale Campos Barbosa; Gifone Aguiar Rocha; Edilberto Nogueira Mendes; Adriana Santos; Paulo Renato Valle Corrêa; Andreia Maria Camargos Rocha; Lúcia Martins Teixeira; Celso Affonso de Oliveira
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

Review 6.  A systematic review of Helicobacter pylori eradication therapy--the impact of antimicrobial resistance on eradication rates.

Authors:  M H Houben; D van de Beek; E F Hensen; A J de Craen; E A Rauws; G N Tytgat
Journal:  Aliment Pharmacol Ther       Date:  1999-08       Impact factor: 8.171

7.  Failed treatment of Helicobacter pylori infection associated with resistance to clarithromycin.

Authors:  D S Tompkins; J Perkin; C Smith
Journal:  Helicobacter       Date:  1997-12       Impact factor: 5.753

8.  Relevance of antibiotic sensitivities in predicting failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori.

Authors:  P Moayyedi; P L Ragunathan; N Mapstone; A T Axon; D S Tompkins
Journal:  J Gastroenterol       Date:  1998       Impact factor: 7.527

9.  The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies.

Authors:  T Lind; F Mégraud; P Unge; E Bayerdörffer; C O'morain; R Spiller; S Veldhuyzen Van Zanten; K D Bardhan; M Hellblom; M Wrangstadh; L Zeijlon; C Cederberg
Journal:  Gastroenterology       Date:  1999-02       Impact factor: 22.682

10.  Is antimicrobial susceptibility testing necessary before second-line treatment for Helicobacter pylori infection?

Authors:  H Miwa; A Nagahara; A Kurosawa; T Ohkusa; R Ohkura; M Hojo; N Enomoto; N Sato
Journal:  Aliment Pharmacol Ther       Date:  2003-06-15       Impact factor: 8.171

View more
  11 in total

1.  Second-line rescue therapy of helicobacter pylori infection.

Authors:  Javier P Gisbert
Journal:  Therap Adv Gastroenterol       Date:  2009-11       Impact factor: 4.409

Review 2.  "Rescue" regimens after Helicobacter pylori treatment failure.

Authors:  Javier P Gisbert
Journal:  World J Gastroenterol       Date:  2008-09-21       Impact factor: 5.742

Review 3.  Systematic review: third-line susceptibility-guided treatment for Helicobacter pylori infection.

Authors:  Ignasi Puig; Sheila López-Góngora; Xavier Calvet; Albert Villoria; Mireia Baylina; Jordi Sanchez-Delgado; David Suarez; Victor García-Hernando; Javier P Gisbert
Journal:  Therap Adv Gastroenterol       Date:  2015-12-16       Impact factor: 4.409

4.  Culture-based antibiotic susceptibility testing for Helicobacter pylori infection: a systematic review.

Authors:  Vincenzo De Francesco; Angelo Zullo; Raffaele Manta; Alissa Satriano; Giulia Fiorini; Matteo Pavoni; Ilaria M Saracino; Fabrizio Giostra; Giorgio Monti; Dino Vaira
Journal:  Ann Gastroenterol       Date:  2022-02-14

Review 5.  Culture-guided treatment approach for Helicobacter pylori infection: review of the literature.

Authors:  Giovanni Cammarota; Gianluca Ianiro; Stefano Bibbò; Teresa Antonella Di Rienzo; Luca Masucci; Maurizio Sanguinetti; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

6.  Rescue Therapy for Helicobacter pylori Infection 2012.

Authors:  Javier P Gisbert
Journal:  Gastroenterol Res Pract       Date:  2012-02-28       Impact factor: 2.260

Review 7.  Treatment of Refractory Helicobacter pylori Infection-Tailored or Empirical Therapy.

Authors:  Jyh-Ming Liou; Yi-Chia Lee; Ming-Shiang Wu
Journal:  Gut Liver       Date:  2022-01-15       Impact factor: 4.519

8.  Efficacy of Phenotype-vs. Genotype-Guided Therapy Based on Clarithromycin Resistance for Helicobacter pylori Infection in Children.

Authors:  Yan Feng; Wenhui Hu; Yuhuan Wang; Junping Lu; Ye Zhang; Zifei Tang; Shijian Miao; Ying Zhou; Ying Huang
Journal:  Front Pediatr       Date:  2022-03-29       Impact factor: 3.418

9.  Saccharomyces boulardii Allows Partial Patients to Avoid Reusing Bismuth Quadruple for Helicobacter pylori Rescue Therapy: A Single-Center Randomized Controlled Study.

Authors:  Peng Qu; Xiaoming Liu; Xiujuan Xia; Xiaoran Xie; Ju Luo; Sha Cheng; Jingshu Chi; Peng Liu; Huan Li; Wenfang Zhao; Huihao Yang; Canxia Xu
Journal:  Front Cell Infect Microbiol       Date:  2022-07-08       Impact factor: 6.073

10.  Tailored Therapy Versus Empiric Chosen Treatment for Helicobacter pylori Eradication: A Meta-Analysis.

Authors:  Han Chen; Yini Dang; Xiaoying Zhou; Bingtuan Liu; Shiyu Liu; Guoxin Zhang
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.